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Abstract
Background: Understanding the survival of resistance plasmids in the absence of selective pressure for the
antibiotic resistance genes they carry is important for assessing the value of interventions to combat resistant
bacteria. Here, several poorly explored questions regarding the fitness impact of IncP1 and IncN broad host range
plasmids on their bacterial hosts are examined; namely, whether related plasmids have similar fitness impacts,
whether this varies according to host genetic background, and what effect antimicrobial resistance gene silencing
has on fitness.
Results: For the IncP1 group pairwise in vitro growth competition demonstrated that the fitness cost of plasmid
RP1 depends on the host strain. For the IncN group, plasmids R46 and N3 whose sequence is presented for the
first time conferred remarkably different fitness costs despite sharing closely related backbone structures,
implicating the accessory genes in fitness. Silencing of antimicrobial resistance genes was found to be beneficial
for host fitness with RP1 but not for IncN plasmid pVE46.
Conclusions: These findings suggest that the fitness impact of a given plasmid on its host cannot be inferred
from results obtained with other host-plasmid combinations, even if these are closely related.
Background
Antibiotic resistance is a serious threat to human and
animal health and new ways to combat it are urgently
needed. Broad-host range plasmids, such as those
belonging to the IncN and IncP1 groups are important
to the dissemination of antibiotic resistance due to their
ability to replicate in a variety clinically relevant bacter-
ial species and environments [1,2]. Indeed, both IncN
and IncP1 group plasmids have been shown to encode
clinically important resistance determinants such as
blaCTX-M, blaIMP, blaNDM, blaVIM and qnr [3-8], whilst
IncN plasmids have also been strongly implicated in the
recent spread of blaKPC encoded carbapenemases [9].
Antimicrobial resistance can sometimes be accompa-
nied by a reduction in biological fitness in the absence
of antibiotic selection. Hence, less fit resistant bacteria
may be outcompeted and displaced by fitter, susceptible
bacteria in the absence of antibiotic use, leading to the
suggestion that it may be possible to reduce the preva-
lence of antibiotic resistance by temporarily restricting
prescribing. In practice, however, such approaches have
enjoyed mixed success [10-14].
A fitness cost of antibiotic resistance has often been
demonstrated in the case of chromosomal mutations
conferring resistance, for example in the case of fusA
mutations conferring resistance to fusidic acid [15] and
gyrA mutations conferring resistance to fluoroquino-
l o n e s[ 1 6 ] .H o w e v e r ,c o m p e n s atory mutations can arise
at secondary sites that reduce or eliminate this cost [17].
I nt h ec a s eo fa c q u i r e da n t i b i o t i cr e s i s t a n c eg e n e s
encoded on mobile genetic elements such as plasmids
and transposons, the existence of a fitness cost is less
clear. While early studies which often investigated clon-
ing plasmids and/or laboratory strains demonstrated a
cost to plasmid carriage [18-21], some more recent data
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teria have failed to demonstrate significant costs and
have sometimes shown a benefit. For example, the small
sulphonamide and streptomycin resistance plasmid
p9123 confers a 4% per generation fitness benefit in E.
coli [22], and a benefit has also been demonstrated for
some apramycin resistance plasmids isolated from
bovine E. coli [23]. A number of antibiotic resistance
encoding plasmids and transposons conferred only a
low fitness cost or were cost-neutral in the wild-type E.
coli strain 345-2RifC in vitro and in the pig gut [24],
whilst the resistance plasmid R751 and variants of it
enhanced fitness under some growth conditions in E.
coli [ 2 5 ] .I ti sl i k e l yt h a tt h ef i t n e s sc o s tap a r t i c u l a r
plasmid exerts on its host is variable depending on the
plasmid as well as on the host itself. However, few stu-
dies have examined the fitness cost of a single plasmid
on different strains of bacteria. The genetic factors, be
they plasmid or host-encoded, that influence fitness are
poorly understood, and it is not known whether related
plasmids influence fitness in similar ways.
There are theoretically three ways in which a bacterial
host can counteract the potential fitness cost exerted by
antibiotic resistance genes carried on mobile genetic ele-
ments; the first is to acquire compensatory mutations,
while the second is outright loss of the mobile genetic ele-
ment. A third possibility is that bacteria could switch off
the expression of resistance genes when they are not
required whilst retaining the genes themselves in order to
lower costs. We have previously demonstrated silencing of
antibiotic resistance genes carried on the broad-host range
plasmids pVE46 and RP1 by the wild-type E. coli strain
345-2RifC [26]. Following passage through the pig gut, a
small proportion (0.5%) of 345-2RifC(pVE46) colonies
recovered lost expression of one or more of the four resis-
tance genes encoded on the plasmid. Such isolates had
retained the pVE46 plasmid and in most cases, intact,
wild-type resistance genes and promoters were present,
but no resistance gene mRNA was expressed. Similar
results were found for three colonies of 345-2RifC(RP1)
that also lost resistance following passage through the pig
gut. Antibiotic resistance gene silencing appears to be
restricted to only the plasmid with minimal effect on the
remainder of the genome and is thought to be due to a
mutation on the chromosome of E. coli 345-2RifC [26]. Its
precise mechanism is yet to be elucidated.
Here, we examine several unexplored questions
regarding the fitness impact of broad host range IncP
and IncN plasmids on their hosts; namely, the effect of
the host background on fitness, whether related plas-
mids have similar fitness impacts and the fitness impact
of antimicrobial resistance gene. To facilitate this task
w ea l s or e p o r tt h ec o m p l e t en u c l e o t i d es e q u e n c eo ft h e
IncN plasmid N3.
Results and discussion
The effect of host background on plasmid fitness impact
The effect of host genetic background on the fitness
impact of plasmid RP1 in the laboratory was investi-
gated (Table 1). Five unrelated host strains representing
all four E. coli phylogenetic groups were studied; E. coli
345-2RifC (group B1) and 343-9 (group D) of porcine
origin, 99-24 (group D) and 99-40 (group B2) of human
c l i n i c a lo r i g i n( u r i n e )a n dK 1 2( g r o u pA )J M 1 0 9 ,a
laboratory strain. Phylogenetic group B2, and to a lesser
extent phylogenetic group D tend to be associated with
extra-intestinal infections, whereas strains belonging to
groups A and B1 are often commensals [27]. There was
considerable variation in the r e s u l t so b t a i n e df r o md i f -
ferent host backgrounds. The fitness impacts of RP1 on
the strains of animal origin (343-9 and 345-8) were sig-
nificantly lower than the costs imposed on those of
human origin (JM109, 99-24 and 99-40) (p < 0.002 in all
cases).
These results suggest that the fitness impact a particu-
lar antibiotic resistance plasmid confers on a given bac-
terial species is dependent on the genotype of the
specific host strain that it is in. This conclusion is per-
haps intuitive, but has to the best of our knowledge not
been demonstrated for antibiotic resistance-encoding
plasmids. One might expect this to be the case based on
previous work by Dahlberg and Chao, who showed that
amelioration of fitness costs conferred by the plasmids
R1 and RP4 (very similar to plasmid RP1 used here) on
E. coli K12 J53 depended on genetic changes in the host
chromosome, thus implying a host genome component
is involved in determining plasmid-encoded fitness cost
[19]. Similarly, the fitness cost and stability of the plas-
mid pB10 was highly variable in strains of different spe-
cies [28,29]. Previous studies have also shown that
target mutations leading to antibiotic resistance, for
example gyrA mutations in Campylobacter jejuni or 23S
rRNA mutations leading to clarithromycin resistance in
Helicobacter pylori have different fitness effects in differ-
ent host backgrounds [30,31]. It is not currently known
which host genetic components may be important for
determining the effect a plasmid will have on host fit-
n e s sa n di ti sl i k e l yt h a tt h e s ew i l lv a r yd e p e n d i n go n
Table 1 In vitro fitness impact of plasmid RP1 on
different E. coli host strains
E. coli Host Strain Fitness impact per generation (%)
345-2RifC -3.3 ± 0.9
343-9 +0.8 ± 0.9
99-24 - 9.1 ± 4.2
99-40 -9.7 ± 1.4
K12 JM109 -5.8 ± 1.0
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has important implications for anyone wishing to use
fitness cost as a parameter to model the spread or
decline of a given plasmid in a bacterial population, per-
haps in response to changes in antimicrobial selection,
as it highlights the need to determine fitness in several
different host genetic backgrounds. Similarly, recent
work has also shown that fitness cost of antimicrobial
resistance is variable depending on the growth condi-
tions used in laboratory measurements [25,32], re-iterat-
ing the need for multiple measurements to obtain
accurate fitness cost estimates.
DNA sequence analysis of N3
Despite being a well-studied archetypal plasmid isolated
in the 1960s, the DNA sequence of the IncN plasmid
N3 has not previously been reported [33]. Sequence
analysis revealed that it is 54 205 bp in length, has a GC
content of 51.1% and encodes 62 putative open reading
frames (Table 2). It shares a common backbone with
other IncN plasmids such as R46 [34] and the recently
described multiple antibiotic resistance plasmid
pKOX105 [3] (Figure 1). The shared region comprises
the plasmid’s replication and transfer functions as well
as genes encoding stable inheritance, anti-restriction and
UV protection functions. N3 also encodes a class 1 inte-
gron and, in common with pKOX105 but lacking from
R46, a type 1 restriction modification system. This char-
acteristic and the high sequence identity shown between
a number of proteins encoded by the two plasmids sug-
gests pKOX105 may have evolved from a N3-like ances-
tor. N3 also encodes a unique region absent from other
known IncN plasmids, bordered by IS26 elements. This
comprises the tet(A) genes for tetracycline resistance, a
putative bacA-l i k eb a c i t r a c i nr e s i s t a n c eg e n ea n ds e v e n
novel genes. Several of the novel genes are predicted to
have metabolic functions, most likely amino acid meta-
bolism. Outside this region, the high similarity between
N3 and other antibiotic resistance encoding IncN plas-
mids suggests that they have evolved from a common
ancestor and diverged from each other relatively
recently. The resistance region appears to have origi-
nated as a single class 1 integron initially carrying only
an aadA1 cassette which has subsequently acquired
further cassettes and/or insertions.
The effect of the genetic composition of the plasmid on
its fitness impact
The fitness impacts of the related plasmids RP1 and
pUB307 and R46 and N3 on E. coli 345-2RifC were
compared. pUB307 is a derivative of RP1 which has lost
the Tn1 transposon. The fitness impact of the Tn1
transposon itself has been demonstrated to be variable
depending on the insertion site, with some insertion
sites conferring a fitness benefit [24]. Here, pUB307 had
a small fitness cost of 1.9 ± 0.8% per generation, signifi-
cantly lower than that of RP1 of -3.3 ± 0.9% per genera-
tion (students t-test p = 0.041). In animals, carriage of
neither RPI nor pUB307 influenced the ability of E. coli
345-2RifC to colonize the pig gut compared to the plas-
mid-free 345-2RifC (ANOVA F value = 0.77, p = 0.471).
R46 was previously determined to confer a fitness cost
of - 3.3 ± 1.7% per generation [24] in the laboratory,
whilst no significant fitness cost in pigs was detected. In
contrast, here, N3 was demonstrated to have a signifi-
cantly higher fitness cost in the laboratory of 9.1 ± 1.8%
per generation (students t-test p = 0.0002). In animals,
345-2RifC/N3 colonised the pig gut significantly worse
than the plasmid free strain or 345-2RifC/R46 (ANOVA
F value = 3.41, p = 0.035).
In the case of RP1 versus pUB307, these results sug-
gest that the lower fitness cost of pUB307 compared to
RP1 is related to the presence of less DNA. It is known
that in single copy the Tn1 transposon does not itself
have a detrimental effect on host fitness and can occa-
sionally confer a benefit depending on the insertion site
[24]. Therefore, it can be assumed that in this case the
advantage gained by deletion of Tn1 is due to the pre-
sence of less DNA and a lowered burden of gene
expression as the TEM beta-lactamase encoded by the
transposon is normally expressed at high levels. As RP1
is present in multiple copies, the burden of gene expres-
sion will be higher on the plasmid than in the case of
Tn1 insertion at a single chromosomal site. Possible
additional epistatic fitness effects due to the insertion
site of Tn1 in RP1 will also be absent in pUB307.
T h er e a s o n ( s )w h yN 3a n dR 4 6h a v em a r k e d l yd i f f e r -
ent fitness costs is less clear, as the two plasmids are a
similar size and share the same replication and conjuga-
tion functions. The marked fitness difference is there-
fore most likely due to accessory genes. The antibiotic
resistance gene complement of the two plasmids is simi-
lar, although not identical (Figure 1, Table 2). The main
differences are the presence of the arsCBADR on R46
and a Type 1 restriction system and a number of puta-
tive metabolic genes on N3. It is likely that one or more
additional genes on N3 are responsible for the high fit-
ness cost of N3 but this hypothesis requires experimen-
tal confirmation. Alternatively, a small mutation in the
core plasmid genome may also be responsible.
The fitness impact of plasmids carrying silent antibiotic
resistance genes
... In addition to variable fitness costs brought about by
different host-plasmid combinations, bacteria may influ-
ence the cost of plasmid carriage by modulation of gene
expression. As antibiotic resistance can impose a fitness
cost on the bacterial host in the absence of antibiotic
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Gene/
orf
Position Putative Function Closest match (Accession)
1 Protein identity
(%)
repA 3-722 Initiation of plasmid replication pKOX105 (ADH29527) 100
ardK 1282-1623 Regulation of ccg genes pEC_L46 (ADL14210) 100
mpr 1638-2429 Zinc metalloproteinase pLEW517 (YP_001096387) 100
mucB 2580-3845 UV protection pKOX105 100
mucA 3833-4273 UV protection pEC_L46 100
ardB 4688-5113 Type I antirestriction system R46 (NP_511215) 99
ardR 5171-5575 Regulator of CUP controlled ccgEII regulon pEC_L46 100
ccgEIII 5585-5824 Unknown R46 100
ccgAI 7332-7511 Regulation of ccgAII expression R46 100
ccgAII 7566-7886 Prevention of RecA overproduction pKOX105 100
pN3_011 7997-8341 Unknown R46 100
stbC 8523-8891 Stable plasmid inheritance R46 100
stbB 8893-9609 Stable plasmid inheritance pKOX105 100
stbA 9618-10037 Stable plasmid inheritance pKOX105 100
traK 10528-10944 Conjugal transfer protein pKOX105 100
traJ 10946-12475 Conjugal transfer protein pKP96 (YP_002332894) 100
traI 12475-15717 Conjugal nickase and helicase pKP96 100
fipA 15717-16343 Fertility inhibition of IncP plasmids pKM101 (AAC63100) 100
nuc 16517-17050 Endonuclease pKOX105 100
traG 17050-18045 Conjugal transfer protein pKOX105 100
traF 18087-19247 Conjugal transfer protein pKOX105 100
traO 19247-20131 Conjugal transfer protein pEC_L46 100
traE 20142-20840 Conjugal transfer protein pEC_L46 100
traN 20830-20967 Conjugal transfer protein pEC_L46 100
traD 21059-22099 Conjugal transfer protein pEC_L46 100
eex 22115-22342 Entry exclusion pKOX105 100
traC 22350-23063 Conjugal transfer protein pKOX105 100
traB 23081-25681 Conjugal transfer protein pKOX105 100
traA 25681-25998 Conjugal transfer protein pKOX105 100
traM 26048-26341 Conjugal transfer protein pKOX105 100
korA 26351-26632 Unknown R46 100
traL 26641-27375 Conjugal transfer protein pKOX105 100
korB 27484-27789 DNA binding protein pKOX105 99
pN3_034 27805-28149 Unknown pKOX105 100
kikA 28146-28460 Killer protein of TrbM family pKOX105 100
pN3_036 28496-28807 Unknown R46 100
mrr 28863-29504 Restriction endonuclease pKOX105 100
pN3_038 29509-29715 Unknown pKP96 100
EcoRII
met
30055-31530 Modification methylase pKOX105 100
EcoRII 31564-32778 Type-2 restriction enzyme pKOX105 100
tnpA 33039-33833 IS6100 transposase pEK499 (YP_003108355) 100
pN3_042 33999-34724 Unknown pAPEC-O1-R (YP_001481449) 100
sul1 34938-35777 Sulphonamide resistant dihydropteroate synthase R46 100
qacEΔ1 35771-36118 Quaternary ammonium compound resistance,
truncated
R46 100
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Figure 1 Schematic representation of the IncN plasmids R46, N3 and pKOX105. Not to scale. Boxes represent individual genes or groups
of genes, described by name or function of the respective gene products. Blocks marked with arrows represent genes unique to each. Crossed
over section between N3 and pKOX105 indicates inverted region. Colour scheme: Yellow- core IncN plasmid function, Green - Type 1 restriction
system, Red - antibiotic and heavy metal resistance, Blue - mobile elements, Turquoise - hypothetical genes, Pink - Putative metabolic genes.
Table 2 Positions and putative functions of open reading frames identified in plasmid N3 (Continued)
aadA2 36282-37073 Aminoglycoside adenyltransferase p1206 (ACC77487) 100
intI1 37219-38232 Class 1 integrase pKOX105 100
uvp1 38625-39194 Site specific recombinase pKOX105 100
tnpA 39506-40210 IS26 transposase pKOX105 100
pN3_049 40247-40750 Putative shikimate dehydrogenase (repeat protein) Pantotea sp. (YP_004116848) 59
tet(A) 41265-42464 Tetracycline efflux protein pQKp331H (ABS19074) 100
tetR 42592-43233 Repressor protein for Tet(A) pQKp331H 100
pN3_052 43438-43941 Unknown No good match
pN3_053 44147-44563 Unknown pLVPK (NP_943518) 59
tnp orfA 44921-45265 IS911 transposase, truncated Shigella flexneri 2a str. 2457 T (NP_835957) 80
pN3_055 45468-46295 Putative bacitracin resistance protein Acinetobacter sp. DR1 (YP_003733303) 62
pN3_056 46450-47589 Putative amino acid racemase Pectobacterium carotovorum PC1
(YP_003017826)
73
pN3_057 47686-48597 Putative LysR-type regulator Shewanella halifaxensis HAW-EB4
(YP_001674862)
56
pN3_058 48594-49526 Putative amino acid dehydrogenase/
cyclodeaminase
Pectobacterium carotovorum subsp.
brasiliensis PBR1692
(ZP_03825565)
72
pN3_059 50018-50623 Putative sodium:dicarboxylate symporter Burkholderia dolosa AUO158 (ZP_04944635) 56
tnpA 50681-51385 IS26 transposase pKOX105 100
hsdM 51636-53192 Type I restriction enzyme EcoprrI M protein Escherichia coli B185 (ZP_06660389) 90
pN3_062 53656-54165 Unknown pKOX105 90
1 Where more than one protein shares the exact same identity with pN3 an example is given
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mid-borne antibiotic resistance genes to confer a fitness
advantage. The fitness costs of the plasmids pVE46 and
RP1 on E. coli 345-2RifC had previously been estab-
lished as moderate in vitro and non-detectable in vivo.
Neither plasmid had a detectable cost in the pig gut
[26]. However, in both cases isolates that no longer
expressed the resistance genes encoded on them but
retained intact and wild-type resistance genes, were
recovered during the pig gut colonisation experiments
[26]. Here, we investigated whether silencing of antibio-
tic resistance genes carried on pVE46 and RP1 had an
effect on their fitness impact.
Three isolates with silent pVE46-encoded antibiotic
resistance genes were investigated in vitro;L 4 ,L 5a n d
L7 (Table 3). Each isolate demonstrated variable degrees
of antibiotic resistance gene silencing [26]. Pair-wise
growth competition assays were performed between
silent isolates and the wild-type isolates expressing all
antibiotic resistance genes. Isolate L5 had a slight in
vitro cost of -2.1% ± 1.7% per generation whilst isolates
L4 and L7 had slight fitness advantages of +1.1 ± 1.4%
and +1.2% ± 0.5% per generation, respectively. However,
the statistical significance of these results was low and
overall the impact of silencing of pVE46 genes on fitness
appeared negligible. The in vivo ability of isolate L5 to
colonize the pig gut was found to be comparable to that
of 345-2RifC(pVE46) (Figure 2).
In contrast, antibiotic resistance gene silencing had a
significant effect on the fitness of E. coli 345-2RifC
(RP1). The silent isolates P1 and P2 (Table 3) both had
fitness advantages of +2.5 ± 0.5% and +4.1 ± 3.7% in
vitro, respectively. P2 was also able to colonize the pig
gut better than 345-2RifC(RP1) (Figure 2).
Surprisingly, antibiotic resistance gene silencing did
not confer a fitness advantage on isolates carrying the
pVE46 plasmid, in vivo or in vitro. This suggests that in
this case antibiotic resistance gene silencing may have
Table 3 Characteristics of bacterial strains and plasmids used in this study
Plasmids Resistance Profile
1 Resistance Genotype Inc Group Reference or source
pVE46 AMP, STR, SUL, TET blaOXA-2, sul1, aadA1, tet(A) N [26]
R46 AMP, STR, SUL, TET blaOXA-2 ×2 ,sul1, aadA1, tet(A) N [34]
RP1 AMP, KAN, TET blaTEM-2, aphA, tet(A) P [35]
PUB307 KAN, TET aphA, tet(A) P [36]
N3 STR, SUL, TET sul1, aadA1, tet(A) N [33]
Bacterial Strains Phylogenetic Group
345-2RifC RIF RpoB H526Y B1 [24]
343-9 NA D [24]
99-24 NA D [11]
99-40 NA B2 [11]
K12 JM109 NAL NA A Promega, Southampton, UK
L5
2 RIF blaOXA-2, sul1, aadA1, tet(A) B1 [26]
L4
2 RIF, TET blaOXA-2, sul1, aadA1, tet(A) B1 [26]
L7
2 AMP, RIF, SUL blaOXA-2, sul1, aadA1 B1 [26]
P1
3 KAN, RIF blaTEM-2 B1 [26]
P2
3 RIF blaTEM-2, aphA, tet(A) B1 [26]
1AMP, ampicillin; KAN, kanamycin; NAL, nalidixic acid; RIF, rifampicin; STR, streptomycin; SUL, sulfamethoxazole; TET, tetracycline; NA, not applicable
2345-2RifC strain with pVE46 encoding silent antimicrobial resistance genes
3345-2RifC strain with RP1 encoding silent antimicrobial resistance genes
1.00E+00
1.00E+01
1.00E+02
1.00E+03
1.00E+04
1.00E+05
1.00E+06
1.00E+07
0 5 10 15 20 25
c
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Figure 2 Recovery of E. coli 345-2RifC(pVE46) (squares), E. coli
L5 (diamonds), E. coli 345-2RifC(RP1) (triangles) and E. coli P2
(circles) from pig faeces following oral inoculation of six
animals. There was statistically no difference in recovery levels
between 345-2RifC(pVE46) and L5 (ANOVA 0.5628, p = 0.4546).
However, P2 was recovered significantly more frequently than 345-
2RifC(RP1) (ANOVA 15.3169, p = 0.0002).
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detected, or that if it exists, any fitness advantage only
manifests itself under conditions not measured by our
current assays. This observation may be explained by
t h ef a c tt h a tt h ei n i t i a lc o s tc o n f e r r e db yc a r r i a g eo f
pVE46 on E. coli 345-2RifC was moderate, 2.8 ± 0.9%,
per generation. However, previous studies did show that
pVE46-encoded antibiotic resistance genes were able to
revert back to resistance at rates varying between 10
-6
and 10
-10 inv i t r o[26] suggesting that such strains may
still pose a clinical threat.
In contrast, silencing of antibiotic resistance genes
encoded on the plasmid RP1 conferred a significant fit-
ness benefit both in vivo and in vitro.S u c has t r a t e g y
could be deemed beneficial for the bacterium, particu-
larly if they were able to revert to antibiotic resistance
again when challenged with antibiotic. However, this
was not the case as none of the isolates with silent RP1
antibiotic resistance genes (P1, P2 or P3) were able to
revert back to resistance in the laboratory. This suggests
that the genetic event responsible for antibiotic resis-
tance gene silencing of RP1 is not readily reversible, for
example a transposon insertion or DNA deletion. Under
such conditions one would expect the silenced DNA to
eventually be lost, but until then it may act as an envir-
onmental reservoir of resistance genes.
In theory any fitness effects observed in silent isolates
could also be attributed to unrelated mutations that
may have arisen in the pig gut prior to their isolation.
However, the silent isolate L5 is not known to carry any
mutations compared to the wild-type 345-2RifC(pVE46)
strain, whilst the possible role of unrelated mutations in
the remaining isolates is yet to be determined (B.H. V.I.
E and N.R.T, unpublished data).
Conclusions
Overall, the results presented here show that the fitness
b a l a n c eb e t w e e nt h eh o s tg e n o t y p ea n dag i v e nr e s i s -
tance plasmid is extremely delicate and that even minor
differences in the host or in the plasmid can have sub-
stantial effects on fitness. Future studies on the subject
should therefore investigate multiple hosts in order to
draw any general conclusions about a particular plasmid.
Without better molecular understanding of the pro-
cesses involved, it is difficult to predict the fitness
impact of a given host-plasmid association, and hence
difficult to make predictions about the spread or decline
of associated antibiotic resistance phenotypes. It is
therefore important to study molecular host-plasmid
interactions. In the absence of such data one should
preferably use a range of host strains and plasmids
when studying the fitness of a particular resistance phe-
notype. As plasmids belonging to the IncN and IncP1
groups are broad-host range and conjugative they will
likely move from host to host until they encounter one
w h e r ec o s t sa r en e g l i g i b l ea n ds u b s e q u e n t l yg oo nt o
thrive with that host. Thus, such plasmids may be of
particular concern in the dissemination of novel antibio-
tic resistance phenotypes.
In addition, bacteria can sometimes “hide” their resis-
tance genotype by silencing it. This can create a fitness
advantage for the bacteria, whereas in other cases the
silent phenotype is reversible, indicating that there is a
risk of treatment failure in anyone infected by bacteria
with silent genes and being treated by one of the
affected antibiotics.
Based on these observations, further work should now
concentrate on understanding the molecular mechan-
isms responsible so that the underlying process are
understood and used to help develop better treatment
and prevention and control strategies.
Methods
Bacterial strains and plasmids
E. coli 345-2RifC, E. coli 345-8 and 343-9 are all com-
mensal isolates of porcine origin. E. coli 345-2RifC is
marked with a no-cost rifampicin-resistance mutation in
RpoB (H526Y). Strains 99-24 and 99-40 are human
urinary isolates, whilst E. coli K12 JM109 is a laboratory
strain. Study strains were chosen on the basis that they
did not carry acquired antibiotic resistance genes and
that they exhibited good growth characteristics in
laboratory media, with doubling ranging between 21 and
27 minutes in nutrient broth. Their phylogenetic group
was determined as described previously [27]. The relat-
edness of the isolates was investigated by randomly
amplified polymorphic DNA (RAPD) PCR [37].
The broad-host range plasmids RP1, pUB307, R46,
pVE46 and N3 were introduced into host strains by
conjugation using the agar mating method [26]. The
345-2RifC(pVE46) strain used was a variant passaged in
the laboratory, the same from which silent isolates arose
[26]. Derivatives of 345-2RifC(pVE46) and 345-2RifC
(RP1), carrying silent antibiotic resistance genes were as
described previously [26]. The characteristics of strains
and plasmids used in this study are listed in Table 3.
DNA sequencing and analysis
DNA of IncN plasmid N3 was prepared by alkaline SDS
maxiprep and CsCl/EtBr density gradient centrifugation
[38]. The E. coli N3 plasmid was sequenced to approxi-
mately 37-fold shotgun sequence, totalling 1711 end
sequences, from pUC19 (with insert sizes of 2-4 kb; 4-6
kb) genomic shotgun libraries that were sequenced
using big-dye terminator chemistry on ABI3730 auto-
mated sequencers. The assembly was generated using
phrap2gap. All repeat regions and gaps were bridged by
read-pairs or end-sequenced polymerase chain reaction
Humphrey et al. BMC Microbiology 2012, 12:53
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Page 7 of 9(PCR) products again sequenced with big dye terminator
chemistry on ABI3730 capillary sequencers. The
sequence was manipulated to the ‘Finished’ standard
[39].
Competition experiments to assay in vitro fitness
To assess the fitness impact of the plasmids upon E. coli
host strains growth competition between plasmid-carry-
ing and plasmid-free isogenic strain pairs was carried
out as described previously in Davis minimal medium
with 25 mg/ml glucose (DM25) [24]. To estimate bac-
terial counts, competition cultures were diluted as
appropriate and spread in triplicate onto IsoSensitest
agar (Oxoid) and onto IsoSensitest agar containing the
relevant antibiotic. For the competition between the
silent strains L5 or L7 and 345-2RifC(pVE46) the agar
contained tetracycline at 25 μg/ml, and for L4 it con-
tained streptomycin at 25 μg/ml. For competition
between 345-2RifC(RP1) and P1 or P2 agar contained
ampicillin at 25 μg/ml. For competition between wild-
type plasmids and their respective host strains it con-
tained ampicillin for RP1 carrying strains, and tetracy-
cline for the pUB307 and N3 carrying strains. Six
replicates of each competition experiment were per-
formed. Average per generation fitness (W) was calcu-
l a t e da sW=1-b ,w h e r ebi se q u a lt oth eg r a d i e n to f
the graph of ln(strain x count/strain y count) per trans-
fer, divided by the number of generations per transfer
(T). T was calculated as ln(dilution factor)/ln(2). The
students t-test was used to estimate the statistical signif-
icance of results.
Investigation of in vitro reversion to resistance
The recovery of resistance by isolates with intact but
silent RP1 encoded resistance genes was investigated by
spreading undiluted and serially diluted overnight nutri-
ent broth cultures onto IsoSensitest agar containing the
appropriate antibiotic (ampicillin, 25 μg/ml; kanamycin
30 μg/ml; tetracycline, 25 μg/ml). To calculate reversion
frequencies, total cell counts were obtained following
plating serial dilutions of the same culture onto antibio-
tic-free medium.
Animal experiments
Animal experiments were carried out using a modified
method of that described previously [24]. For each
experiment, six organic piglets from two litters of Sad-
dleback-Duroc cross, weaned at five weeks of age, were
housed as a single group for two weeks, to allow the
animals to acclimatize to their surroundings. They were
then randomly separated into two groups of three into
pens with individual HEPA filtration and fed a standard
organic feed (Organic feed company, grower/finisher
pellets, UK) ad libitum. All procedures complied with
the Animals (Scientific Procedures) Act 1986 and were
performed under Home Office License.
Briefly, bacterial strains (E. coli 345-2RifC(pVE46),
345-2RifC(RP1), L5 and P1) were inoculated separately
into six piglets as a single dose of 10
10 cfu per animal
by oral gavage. Faecal samples were collected from each
animal by digital manipulation on day 3, 5, 7, 10, 12, 14,
17, 19 and 21 post-inoculation and analysed within 24
hours. One gram of faeces was suspended in nine milli-
litres of saline and plated at appropriate dilutions onto
six MacConkey agar plates containing 50 μg/ml rifampi-
cin (detection limit 2 cfu/g). They were incubated over-
night at 37°C and colonies obtained replica plated onto
MacConkey agar containing 50 μg/ml rifampicin with
ampicillin (25 μg/ml), tetracycline (25 μg/ml), sulfa-
methoxazole (500 μg/ml) or streptomycin (25 μg/ml) for
L5, and rifampicin with ampicillin, tetracycline or kana-
mycin (30 μg/ml) for P1, followed by replica plating
onto MacConkey agar with rifampicin only.
Nucleotide sequence accession number
The N3 DNA sequence has been submitted to EMBL
under the accession number FR850039.
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